CLEARWATER, Fla., Aug. 1, 2018 /PRNewswire/ -- Acacia Diversified Holdings, Inc. ("Acacia" or the "Company") (OTCQB symbol:ACCA), an emerging cannabis company, through its wholly owned subsidiaries, MariJ Pharmaceuticals, Inc. (MariJ) and Eufloria Medical of Tennessee, Inc. (Eufloria) focused on the growing and distribution of new and proprietary
"We are please, for our shareholders and customers, to share this improvement and efficient step. In addition to being fully HIPAA compliant and cloud based on a HL7 platform, I am excited to let our shareholders know, owning the code, we can now offer licensing agreements for other cannabis companies wanting to be HIPAA compliant from left to right or seed to sale and Doctor to Patient," said Richard K. Pertile, Acacia's Chief Executive Officer.
Forward-Looking StatementsStatements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.
View original content:http://www.prnewswire.com/news-releases/acacia-diversified-holdings-inc-acquires-medahub-technology-companies-300689170.html
SOURCE Acacia Diversified Holdings, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All